| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeafb6c61146824c44bccb18cf449c35 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2010-02-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec760f843616b6ef4bdf49231b030e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd47a20595b8f323b608c8b8b974b883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f241bf7a7dc389d0235bbfcd121aab7 |
| publicationDate |
2010-09-02^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2753499-A1 |
| titleOfInvention |
A drug identification protocol for type 2 diabetes based on gene expression signatures |
| abstract |
The present invention relates generally to the field of drug identification and evaluation and therapeutic optimiza-tion. More particularly, the present invention provides a protocol for identifying compounds useful in the treatment of TNF.alpha. asso-ciated diabetes or a condition associated with diabetes based on a signature of genomic or proteomic expression. Diagnostic and prognostic protocols for diabetes and conditions associated therewith also form part of the present invention. Optimization of ther-apeutic intervention is also encompassed by the present invention. |
| priorityDate |
2009-02-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |